A Randomized Double-Blind Controlled Study of CS-8958 Versus Oseltamivir Phosphate in Patients With Influenza Virus Infection.

Trial Profile

A Randomized Double-Blind Controlled Study of CS-8958 Versus Oseltamivir Phosphate in Patients With Influenza Virus Infection.

Completed
Phase of Trial: Phase III

Latest Information Update: 29 Nov 2011

At a glance

  • Drugs Laninamivir; Oseltamivir
  • Indications Influenza A virus H1N1 subtype; Influenza A virus infections; Influenza B virus infections
  • Focus Registrational; Therapeutic Use
  • Acronyms MARVEL
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 11 Oct 2010 Results published in Clinical Infectious Diseases.
    • 10 Aug 2009 Top-line results reported in a Daiichi Sankyo Company media release.
    • 10 Aug 2009 Data from this trial will be used in the NDA submission to the US FDA, according to a Daiichi Sankyo Company media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top